Migraine Drug Shows Promise as IBS Treatment in Small Trial

(MedPage Today) — PHOENIX — A migraine medication targeting calcitonin gene-related peptide (CGRP) pathways wasn’t shown to improve daily abdominal pain scores in irritable bowel syndrome (IBS), but it may help reduce gut pain sensitivity…

Source link : https://www.medpagetoday.com/meetingcoverage/acg/118234

Author :

Publish date : 2025-10-30 17:34:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Migraine Drug Shows Promise as IBS Treatment in Small Trial

Hospitals Struggle as Consultant Posts Remain Unfilled

Expert Warns of Irreparable Damage to Biotech Industry Unless Congress Acts

Related Posts

Tirzepatide Matches Competitor’s Cardioprotective Benefits for Diabetics

Gout and Its Comorbidities

Combination Model May Improve Diagnosis of Serious Respiratory Infections

High-Fat Cheese May Have Cognitive Benefit, Study Suggests

Four Republicans Defy House Speaker to Force Vote on Extending ACA Subsidies

Two Extended-Release Buprenorphine Doses Effective in High-Risk Opioid Use Disorder

Tirzepatide Matches Competitor’s Cardioprotective Benefits for Diabetics

Gout and Its Comorbidities

Combination Model May Improve Diagnosis of Serious Respiratory Infections

High-Fat Cheese May Have Cognitive Benefit, Study Suggests

Four Republicans Defy House Speaker to Force Vote on Extending ACA Subsidies

Two Extended-Release Buprenorphine Doses Effective in High-Risk Opioid Use Disorder

Major Developments in Psoriatic Disease

ADHD App Cleared; Anti-Inflammatories for Depression; Charges Over Adderall Scripts

Categories

Archives